Bezitramide

Bezitramide

SCHEMBL28086184

CC(C)=CCN1CC[C@@]2(C)c3cc(O)ccc3C[C@@H]1[C@@H]2C.CCC(=O)n1c(=O)n(C2CCN(CCC(C#N)(c3ccccc3)c3ccccc3)CC2)c2ccccc21

nearest known ligand 0.52

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

SIGMAR1

The experimentally established mechanism targets of Bezitramide. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 11)

geneUniProtsupporting neighboursconfidence
SIGMAR1 known ✓ Q99720 10/20 0.52
OPRM1 P35372 7/20 0.52
OPRD1 P41143 5/20 0.52
OPRK1 P41145 5/20 0.52
TMEM97 Q5BJF2 3/20 0.52
EBP Q15125 2/20 0.52
CYP1A2 P05177 1/20 0.44
CYP3A4 P08684 1/20 0.44
CYP2D6 P10635 1/20 0.44
TSHR P16473 1/20 0.44
NPSR1 Q6W5P4 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Bezitramide SCHEMBL25733 0.79 OPRM1 (0.55) OPRM1NPSR1
Bezitramide SCHEMBL29387545 0.79 OPRM1 (0.55) OPRM1NPSR1
Pentazocine SCHEMBL29801598 0.73 SIGMAR1 (0.98) SIGMAR1OPRM1OPRD1OPRK1TMEM97
Pentazocine SCHEMBL31568850 0.72 OPRM1 (0.81) SIGMAR1OPRM1OPRD1OPRK1TMEM97
(+)-Pentazocine SCHEMBL680675 0.72 SIGMAR1 (1.00) SIGMAR1OPRM1OPRD1OPRK1TMEM97
(+)-Pentazocine SCHEMBL4376337 0.72 SIGMAR1 (1.00) SIGMAR1OPRM1OPRD1OPRK1TMEM97
(+)-Pentazocine SCHEMBL2492 0.72 SIGMAR1 (1.00) SIGMAR1OPRM1OPRD1OPRK1TMEM97
(+)-Pentazocine SCHEMBL18672553 0.72 SIGMAR1 (1.00) SIGMAR1OPRM1OPRD1OPRK1TMEM97
(+)-Pentazocine SCHEMBL22865258 0.72 SIGMAR1 (1.00) SIGMAR1OPRM1OPRD1OPRK1TMEM97
Pentazocine SCHEMBL2493 0.72 SIGMAR1 (1.00) SIGMAR1OPRM1OPRD1OPRK1TMEM97

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-103717597-B Heterocyclic compounds as kinase inhibitors 原真股份有限公司 2017-07-04 CN disclosed
CN-103492389-B Pyrazolo [4,3-d] pyrimidine as inhibitors of kinases 原真股份有限公司 2016-09-14 CN disclosed